An experimental treatment has been developed by the Scientists from Baylor College of Medicine in Houston for Type 1 diabetes.

The team had tried to control the two major defects, which are responsible for Type 1 diabetes, by using effective gene therapy. These defects are autoimmune attack and destruction of the insulin-producing beta cells.

In the experiment, a non-obese mouse has been used, which impulsively develop diabetes due to autoimmunity, just as it develops in humans.

"A single treatment cured about 50% of the diabetic mice, restoring their blood sugar to normal so that they no longer need insulin injections," said study co-author Lawrence Chan, Chief of Baylor’s diabetes, endocrinology and metabolism division.

Type 1 diabetes develops when the immune system of the body attacks and destroys the beta cells in the pancreas, which is also called as the insulin factory of the body. This results in the deficiency of insulin, which controls blood sugar and it ultimately leads to high blood sugar and thus diabetes.

The researchers have added the original gene therapy, which protects the newly produced beta cells from the autoimmune attack. The new added gene was for interleukin-10, an imperative regulator of the immune system.